Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 36104 MINNEAPOLIS, MN
Back to BTAI Full portfolio

Position in BTAI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $34,968,542 across 41 Drug Manufacturers - Specialty & Generic names. BTAI ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TAK
Takeda Pharmaceutical Co Ltd
 466,714 $7,481,424
2 HLN
Haleon plc
 650,820 $6,072,149
3 TEVA
Teva Pharmaceutical Industries Ltd
 155,892 $5,281,619
4 ZTS
Zoetis Inc.
 54,002 $3,880,582
5 VTRS
Viatris Inc
 220,066 $3,494,647
6 RDY
Dr Reddys Laboratories Ltd
 189,028 $2,739,015
7 LNTH
Lantheus Holdings, Inc.
 11,941 $1,324,734
8 HIMS
Hims & Hers Health, Inc.
 29,837 $1,034,448

All Filings in BTAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1 1
2026-03-31 $1 1
2025-12-31 $1 1
2025-09-30 $2 1
2025-06-30 $1 1
2025-03-31 $2 1
2024-12-31 $12 33
2024-09-30 $11,000 18,033
2024-06-30 $23,639 18,468
2024-03-31 $50,853 18,033
2023-12-31 $53,197 18,033
2023-09-30 $45,623 18,033
2023-06-30 $93,719 14,072
2023-03-31 $615 33
2022-12-31 $708 33
2022-09-30 $4,905 415
2022-06-30 $8,065 611
2022-03-31 $14,992 717
2021-12-31 $16,812 827
2021-09-30 $31,867 1,050
2021-06-30 $40,625 1,398
2021-03-31 $212,174 4,916
2020-12-31 $238,438 5,161
2020-09-30 $207,650 4,789
2020-06-30 $123,830 2,336
2020-03-31 $67,674 3,028